What a new commercial model to engage with HCPs should look like
Here’s an excerpt from the original publication – click here to view the full article.
The industry needs to offer increased flexibility, allowing healthcare professionals to choose how and when to engage while meeting an increased demand for demonstrable value in medicines. This demands agility from commercial models that has previously been unavailable.
One of the many obstacles slowing the pace of change is that businesses that have succeeded under antiquated models will advocate for business as usual.
While this approach may work in the short-term, the successful model that will be in place in ten years’ time is very different and those who don’t adopt this soon will pay a price.
Click here to read the rest of the article originally published by PharmaTimes.